You are here

Europe follows FDA to get nod for early stage Alzheimer's therapies

London

EUROPEAN regulators are following in the footsteps of the US Food and Drug Administration (FDA) with plans to help pharmaceutical companies win approval for novel Alzheimer's drugs that treat the earliest stages of the memory-robbing disease.

The European Medicines Agency

sentifi.com

Market voices on: